Identification of autophagy related genes in predicting the prognosis and aiding 5- fluorouracil therapy of colorectal cancer

• Published in: Heliyon Vol. 8; no. 3; p. e09033
• Main Authors: Gao, Tianyi, Yuan, Dan, He, Bangshun, Gao, Yingdong, Liu, Caidong, Sun, Huilin, Nie, Junjie, Wang, Shukui, Nie, Zhenlin
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.03.2022; Elsevier
• Subjects: 5-Fluorouracil resistance; Autophagy; Colorectal cancer; colorectal neoplasms; fluorouracil; HSPB8; macrophages; monocytes; prognosis; therapeutics; 5-Fluorouracil resistance; Autophagy; HSPB8; Colorectal cancer
• ISSN: 2405-8440; 2405-8440
• DOI: 10.1016/j.heliyon.2022.e09033

The emergence of 5-Fluorouracil (5-FU) resistance is the barrier to effective clinical outcomes for colorectal cancer (CRC) patients. Autophagy was found to be involved in protecting tumor cells from 5-FU. However, the specific role of autophagy-related genes in CRC 5-FU resistance remains unclear. In this study, HSPB8 among 34 differentially expressed ARGs in CRC was identified to be the hub ARGs in 5-FU resistant which was down-regulated in CRC samples when compared with normal samples but up-regulated in CRC samples with relatively higher lymphatic invasion, later stages and poor prognosis of CRC. Mechanistic analysis demonstrated that due to the recruitment of CAFs, HSPB8 expression was enhanced in CRC cells so that HSPB8 could act together with its co-chaperone BAG3 in autophagy drived 5-FU resistance. Furthermore, the augmented expression level of HSPB8 was found to be significantly correlated to the immune cell infiltration such as Treg cells, macrophages, monocyte and dendritic cells and so on. Our results suggested CAFs driving HSPB8 induced CRC 5-FU resistance by promoting tumor autophagy would provide a new strategy in seeking potential CRC therapeutic target. Colorectal cancer; Autophagy; HSPB8; 5-fluorouracil resistance.